IE000K54GGV6
IE000K54GGV6
US Research Enhanced Index Equity Active UCITS ETF
Loading chart...
About this ETF
The ETF invests in companies that either come from the USA or carry out most of their economic activities the USA. This fund seeks to generate a higher return than the S&P 500. In addition, the fund management avoids companies whose ESG performance has a negative impact on operations or whose business practices do not conform to the fund management's standards. Currency hedged to Swiss Francs (CHF).
TER
0.2%
Total Expense Ratio per year
Fund Size
€13.83B
Assets under management
Holdings
257
Underlying equities
Dividend Yield
0%
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
24.45
Weighted Fwd P/E
17.71
💰 Revenue Estimates
Current Year CY
+27.29% ⌀ 33 Analysts Coverage
Next Year NY
+19.29% ⌀ 34 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
+41.37% ⌀ 31 Analysts Coverage
Next Year NY
+20.47% ⌀ 32 Analysts Coverage
Related ETFs
US Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF
43.53 USD
TER 0.2% 1Y +14.3%
US Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF
37.22 EUR
TER 0.2%
US Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF
42.78 USD
TER 0.2% 1Y +13.8%
US Research Enhanced Index Equity SRI Paris Aligned Active UCITS ETF
32.58 CHF
TER 0.2% 1Y +9.6%
ETF Profile
Provider
Fund Type
ETF Type
Actively Managed Inception Date
04/26/2022 (4 yrs)
Region
-
Country
United States Sector
-
Strategy
Social / Environmental Theme
-
Distribution Policy
Accumulating Replication
Full replication Sustainable
Yes 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
5/7 Elevated
Diversification Score: 68/100 Moderate
Diversification Score
68/100 Moderate
5Y Volatility
16.4% p.a.
Max Drawdown (5Y)
-21.6%
Sharpe Ratio (5Y)
0.54
Beta Factor
0.00
Notes & Warnings
Fund Volume (AUM) 🟢 Established large fund (> 500M € AUM)
⚠️ Sector concentration: 40% in "Technology".
⚠️ Elevated Regulatory & Policy Risk: 39% in heavily regulated industries (defense, regulated utilities, healthcare policy).